{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:24:16Z","timestamp":1781735056592,"version":"3.54.5"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the High level medical and health talents in Jinan City\uff0cand 552 Shandong Province Medical and Health Science and Technology Development Program Project","award":["202204040490"],"award-info":[{"award-number":["202204040490"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["821713273"],"award-info":[{"award-number":["821713273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12054-y","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T09:40:24Z","timestamp":1754041224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Higher levels of plasma phosphatidylcholine (17:0_18:1) raise the risk of developing Parkinson\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Daoqing","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinye","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"11","key":"12054_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","volume":"157","author":"SK Van Den Eeden","year":"2003","unstructured":"Van Den Eeden, S. K. et al. Incidence of Parkinson\u2019s disease: Variation by age, gender, and race\/ethnicity. Am. J. Epidemiol. 157(11), 1015\u20131022 (2003).","journal-title":"Am. J. Epidemiol."},{"key":"12054_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.956440","volume":"13","author":"IC Lampropoulos","year":"2022","unstructured":"Lampropoulos, I. C., Malli, F., Sinani, O., Gourgoulianis, K. I. & Xiromerisiou, G. Worldwide trends in mortality related to Parkinson\u2019s disease in the period of 1994\u20132019: Analysis of vital registration data from the WHO mortality database. Front. Neurol. 13, 956440 (2022).","journal-title":"Front. Neurol."},{"issue":"8","key":"12054_CR3","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes, O. B. & Storstein, A. Epidemiology of Parkinson\u2019s disease. J Neural Transm. 124(8), 901\u2013905 (2017).","journal-title":"J Neural Transm."},{"key":"12054_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou, Z. et al. Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front. Publ. Health. 9, 776847 (2021).","journal-title":"Front. Publ. Health."},{"issue":"11","key":"12054_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R. et al. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: A systematic analysis for the global burden of disease study 2016. Lancet Neurol. 17(11), 939\u2013953 (2018).","journal-title":"Lancet Neurol."},{"issue":"3","key":"12054_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrneurol.2016.14","volume":"12","author":"JF Baizabal-Carvallo","year":"2016","unstructured":"Baizabal-Carvallo, J. F. & Jankovic, J. Parkinsonism, movement disorders and genetics in frontotemporal dementia. Nat. Rev. Neurol. 12(3), 175\u2013185 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"12054_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.pbr.2019.10.006","volume":"252","author":"AM Schonhoff","year":"2020","unstructured":"Schonhoff, A. M., Williams, G. P., Wallen, Z. D., Standaert, D. G. & Harms, A. S. Innate and adaptive immune responses in Parkinson\u2019s disease. Prog. Brain Res. 252, 169\u2013216 (2020).","journal-title":"Prog. Brain Res."},{"issue":"12","key":"12054_CR8","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.tins.2019.10.002","volume":"42","author":"RL Wallings","year":"2019","unstructured":"Wallings, R. L., Humble, S. W., Ward, M. E. & Wade-Martins, R. Lysosomal dysfunction at the centre of Parkinson\u2019s disease and frontotemporal dementia\/amyotrophic lateral sclerosis. Trends Neurosci. 42(12), 899\u2013912 (2019).","journal-title":"Trends Neurosci."},{"issue":"11","key":"12054_CR9","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/antiox9111063","volume":"9","author":"DL Ju\u00e1rez-Flores","year":"2020","unstructured":"Ju\u00e1rez-Flores, D. L. et al. Disrupted mitochondrial and metabolic plasticity underlie comorbidity between age-related and degenerative disorders as Parkinson disease and type 2 diabetes mellitus. Antioxidants 9(11), 1063 (2020).","journal-title":"Antioxidants"},{"key":"12054_CR10","doi-asserted-by":"publisher","first-page":"1370837","DOI":"10.1155\/2020\/1370837","volume":"2020","author":"MA Robea","year":"2020","unstructured":"Robea, M. A. et al. Parkinson\u2019s disease-induced zebrafish models: Focussing on oxidative stress implications and sleep processes. Oxid. Med. Cell Longev. 2020, 1370837 (2020).","journal-title":"Oxid. Med. Cell Longev."},{"key":"12054_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","volume":"226","author":"C Raza","year":"2019","unstructured":"Raza, C., Anjum, R. & Shakeel, N. U. A. Parkinson\u2019s disease: Mechanisms, translational models and management strategies. Life Sci. 226, 77\u201390 (2019).","journal-title":"Life Sci."},{"issue":"7626","key":"12054_CR12","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/538S1a","volume":"538","author":"M Grayson","year":"2016","unstructured":"Grayson, M. Parkinson\u2019s disease. Nature 538(7626), S1 (2016).","journal-title":"Nature"},{"issue":"9","key":"12054_CR13","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.3390\/ijms21093301","volume":"21","author":"A Mori","year":"2020","unstructured":"Mori, A., Imai, Y. & Hattori, N. Lipids: Key players that modulate \u03b1-synuclein toxicity and neurodegeneration in Parkinson\u2019s disease. Int. J. Mol. Sci. 21(9), 3301 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 7","key":"12054_CR14","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/brain\/awp044","volume":"132","author":"J Neumann","year":"2009","unstructured":"Neumann, J. et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease. Brain 132(Pt 7), 1783\u20131794 (2009).","journal-title":"Brain"},{"issue":"17","key":"12054_CR15","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky, E. et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N. Engl. J. Med. 361(17), 1651\u20131661 (2009).","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"12054_CR16","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1212\/WNL.0b013e31828f180e","volume":"80","author":"Z Gan-Or","year":"2013","unstructured":"Gan-Or, Z. et al. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology 80(17), 1606\u20131610 (2013).","journal-title":"Neurology"},{"issue":"10","key":"12054_CR17","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ng.3955","volume":"49","author":"D Chang","year":"2017","unstructured":"Chang, D. et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci. Nat. Genet. 49(10), 1511\u20131516 (2017).","journal-title":"Nat. Genet."},{"issue":"12","key":"12054_CR18","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1093\/brain\/awx285","volume":"140","author":"LA Robak","year":"2017","unstructured":"Robak, L. A. et al. Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease. Brain 140(12), 3191\u20133203 (2017).","journal-title":"Brain"},{"issue":"12","key":"12054_CR19","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Sim\u00f3n-S\u00e1nchez","year":"2009","unstructured":"Sim\u00f3n-S\u00e1nchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet. 41(12), 1308\u20131312 (2009).","journal-title":"Nat Genet."},{"issue":"9","key":"12054_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat. Genet. 46(9), 989\u2013993 (2014).","journal-title":"Nat. Genet."},{"issue":"2","key":"12054_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.celrep.2015.12.022","volume":"14","author":"HL Goldschmidt","year":"2016","unstructured":"Goldschmidt, H. L. et al. DGK\u03b8 catalytic activity is required for efficient recycling of presynaptic vesicles at excitatory synapses. Cell Rep. 14(2), 200\u2013207 (2016).","journal-title":"Cell Rep."},{"issue":"10","key":"12054_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tcb.2013.05.002","volume":"23","author":"D Puchkov","year":"2013","unstructured":"Puchkov, D. & Haucke, V. Greasing the synaptic vesicle cycle by membrane lipids. Trends Cell Biol. 23(10), 493\u2013503 (2013).","journal-title":"Trends Cell Biol."},{"issue":"6","key":"12054_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002141","volume":"7","author":"CB Do","year":"2011","unstructured":"Do, C. B. et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson\u2019s disease. PLoS Genet. 7(6), e1002141 (2011).","journal-title":"PLoS Genet."},{"issue":"52","key":"12054_CR24","doi-asserted-by":"publisher","first-page":"E12228","DOI":"10.1073\/pnas.1813458115","volume":"115","author":"JH Lee","year":"2018","unstructured":"Lee, J. H. et al. SREBP-1a-stimulated lipid synthesis is required for macrophage phagocytosis downstream of TLR4-directed mTORC1. Proc. Natl. Acad. Sci. USA. 115(52), E12228\u2013E12234 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"7","key":"12054_CR25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian, S. H. et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22(7), 1099\u20131109 (2019).","journal-title":"Nat. Neurosci."},{"issue":"8\u20139","key":"12054_CR26","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s007020070051","volume":"107","author":"J Klein","year":"2000","unstructured":"Klein, J. Membrane breakdown in acute and chronic neurodegeneration: Focus on choline-containing phospholipids. J Neural Transm. 107(8\u20139), 1027\u20131063 (2000).","journal-title":"J Neural Transm."},{"issue":"8","key":"12054_CR27","doi-asserted-by":"publisher","first-page":"18865","DOI":"10.3390\/ijms160818865","volume":"16","author":"K Farmer","year":"2015","unstructured":"Farmer, K., Smith, C. A., Hayley, S. & Smith, J. Major alterations of phosphatidylcholine and lysophosphotidylcholine lipids in the substantia Nigra using an early-stage model of Parkinson\u2019s disease. Int. J. Mol. Sci. 16(8), 18865\u201318877 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"12054_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yclnex.2018.05.001","volume":"20","author":"A Shamim","year":"2018","unstructured":"Shamim, A., Mahmood, T., Ahsan, F., Kumar, A. & Bagga, P. Lipids: An insight into the neurodegenerative disorders. Clin. Nutr. Exp. 20, 1\u201319 (2018).","journal-title":"Clin. Nutr. Exp."},{"issue":"1","key":"12054_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1139\/o03-092","volume":"82","author":"MM Wright","year":"2004","unstructured":"Wright, M. M., Howe, A. G. & Zaremberg, V. Cell membranes and apoptosis: Role of cardiolipin, phosphatidylcholine, and anticancer lipid analogues. Biochem. Cell Biol. 82(1), 18\u201326 (2004).","journal-title":"Biochem. Cell Biol."},{"issue":"2","key":"12054_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1471-4892(01)00024-8","volume":"1","author":"CH Macphee","year":"2001","unstructured":"Macphee, C. H. Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target. Curr. Opin. Pharmacol. 1(2), 121\u2013125 (2001).","journal-title":"Curr. Opin. Pharmacol."},{"key":"12054_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1476-511X-6-17","volume":"6","author":"LA Taylor","year":"2007","unstructured":"Taylor, L. A., Arends, J., Hodina, A. K., Unger, C. & Massing, U. Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status. Lipids Health Dis. 6, 17 (2007).","journal-title":"Lipids Health Dis."},{"issue":"Pt 1","key":"12054_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/BJ20041389","volume":"387","author":"A Goonesinghe","year":"2005","unstructured":"Goonesinghe, A. et al. Pro-apoptotic Bid induces membrane perturbation by inserting selected lysolipids into the bilayer. Biochem. J. 387(Pt 1), 109\u2013118 (2005).","journal-title":"Biochem. J."},{"issue":"4","key":"12054_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/emm.2006.44","volume":"38","author":"DH Yun","year":"2006","unstructured":"Yun, D. H., Jeon, E. S., Sung, S. M., Ryu, S. H. & Kim, J. H. Lysophosphatidylcholine suppresses apoptosis and induces neurite outgrowth in PC12 cells through activation of phospholipase D2. Exp. Mol. Med. 38(4), 375\u2013384 (2006).","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"12054_CR34","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00702-003-0007-9","volume":"110","author":"C Mulder","year":"2003","unstructured":"Mulder, C. et al. Decreased lysophosphatidylcholine\/phosphatidylcho\u2014line ratio in cerebrospinal fluid in Alzheimer\u2019s disease. J. Neural. Transm. (Vienna). 110(8), 949\u2013955 (2003).","journal-title":"J. Neural. Transm. (Vienna)."},{"issue":"6","key":"12054_CR35","first-page":"887","volume":"71","author":"A Drzazga","year":"2014","unstructured":"Drzazga, A., Sowi\u0144ska, A. & Kozio\u0142kiewicz, M. Lysophosphatidylcholine and lysophosphatidylinosiol-novel promissing signaling molecules and their possible therapeutic activity. Acta. Pol. Pharm. 71(6), 887\u2013899 (2014).","journal-title":"Acta. Pol. Pharm."},{"issue":"10","key":"12054_CR36","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.clinbiochem.2005.06.006","volume":"38","author":"B Fuchs","year":"2005","unstructured":"Fuchs, B., Schiller, J., Wagner, U., H\u00e4ntzschel, H. & Arnold, K. The phosphatidylcholine\/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: Investigations by 31P NMR and MALDI-TOF MS. Clin. Biochem. 38(10), 925\u2013933 (2005).","journal-title":"Clin. Biochem."},{"issue":"1","key":"12054_CR37","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1038\/s41467-023-42532-8","volume":"14","author":"L Ottensmann","year":"2023","unstructured":"Ottensmann, L. et al. Genome-wide association analysis of plasma lipidome identifies 495 genetic associations. Nat. Commun. 14(1), 6934 (2023).","journal-title":"Nat. Commun."},{"issue":"10","key":"12054_CR38","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9, V. et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat. Genet. 52(10), 1036\u20131045 (2020).","journal-title":"Nat. Genet."},{"issue":"9","key":"12054_CR39","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao, J. H. et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat. Immunol. 24(9), 1540\u20131551 (2023).","journal-title":"Nat. Immunol."},{"issue":"10","key":"12054_CR40","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue, S. et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat. Genet. 53(10), 1415\u20131424 (2021).","journal-title":"Nat. Genet."},{"key":"12054_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: Rising to the challenge of larger and richer datasets. Gigascience. 4, 7 (2015).","journal-title":"Gigascience."},{"key":"12054_CR42","doi-asserted-by":"publisher","first-page":"562434","DOI":"10.3389\/fgene.2020.562434","volume":"11","author":"A van der Graaf","year":"2020","unstructured":"van der Graaf, A. et al. Systematic prioritization of candidate genes in disease loci identifies TRAFD1 as a master regulator of IFN\u03b3 signaling in celiac disease. Front Genet. 11, 562434 (2020).","journal-title":"Front Genet."},{"issue":"7","key":"12054_CR43","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"30","author":"G Hemani","year":"2018","unstructured":"Hemani, G. et al. The MR-base platform supports systematic causal inference across the human phenome. Elife 30(7), e34408 (2018).","journal-title":"Elife"},{"issue":"4","key":"12054_CR44","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 40(4), 304\u2013314 (2016).","journal-title":"Genet Epidemiol."},{"issue":"2","key":"12054_CR45","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44(2), 512\u2013525 (2015).","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"12054_CR46","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/gepi.22295","volume":"44","author":"EAW Slob","year":"2020","unstructured":"Slob, E. A. W. & Burgess, S. A comparison of robust Mendelian randomization methods using summary data. Genet. Epidemiol. 44(4), 313\u2013329 (2020).","journal-title":"Genet. Epidemiol."},{"issue":"R1","key":"12054_CR47","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith, G. & Hemani, G. Mendelian randomization: Genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23(R1), R89-98 (2014).","journal-title":"Hum. Mol. Genet."},{"issue":"25","key":"12054_CR48","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1002\/sim.9133","volume":"40","author":"E Sanderson","year":"2021","unstructured":"Sanderson, E., Spiller, W. & Bowden, J. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization. Stat. Med. 40(25), 5434\u20135452 (2021).","journal-title":"Stat. Med."},{"issue":"12","key":"12054_CR49","first-page":"2681","volume":"187","author":"J Bowden","year":"2018","unstructured":"Bowden, J., Hemani, G. & Davey, S. G. Invited commentary: Detecting individual and global horizontal pleiotropy in Mendelian randomization-a job for the humble heterogeneity statistic?. Am. J. Epidemiol. 187(12), 2681\u20132685 (2018).","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"12054_CR50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","volume":"28","author":"S Burgess","year":"2017","unstructured":"Burgess, S., Bowden, J., Fall, T., Ingelsson, E. & Thompson, S. G. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology 28(1), 30\u201342 (2017).","journal-title":"Epidemiology"},{"issue":"3","key":"12054_CR51","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce, B. L., Ahsan, H. & Vanderweele, T. J. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int. J. Epidemiol. 40(3), 740\u2013752 (2011).","journal-title":"Int. J. Epidemiol."},{"issue":"20","key":"12054_CR52","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","volume":"32","author":"JR Staley","year":"2016","unstructured":"Staley, J. R. et al. PhenoScanner: A database of human genotype-phenotype associations. Bioinformatics 32(20), 3207\u20133209 (2016).","journal-title":"Bioinformatics"},{"issue":"5","key":"12054_CR53","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50(5), 693\u2013698 (2018).","journal-title":"Nat. Genet."},{"issue":"5","key":"12054_CR54","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"MJ Brion","year":"2013","unstructured":"Brion, M. J., Shakhbazov, K. & Visscher, P. M. Calculating statistical power in Mendelian randomization studies. Int. J. Epidemiol. 42(5), 1497\u20131501 (2013).","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"12054_CR55","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.atherosclerosis.2013.02.028","volume":"228","author":"JA van Diepen","year":"2013","unstructured":"van Diepen, J. A., Berb\u00e9e, J. F., Havekes, L. M. & Rensen, P. C. Interactions between inflammation and lipid metabolism: Relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis. Atherosclerosis 228(2), 306\u2013315 (2013).","journal-title":"Atherosclerosis"},{"key":"12054_CR56","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MCHD-0035-2016","author":"M Bennett","year":"2016","unstructured":"Bennett, M. & Gilroy, D. W. Lipid mediators in inflammation. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.MCHD-0035-2016 (2016).","journal-title":"Microbiol Spectr."},{"issue":"8","key":"12054_CR57","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.neurobiolaging.2012.02.014","volume":"33","author":"H Shi","year":"2012","unstructured":"Shi, H. et al. Genetic variants influencing human aging from late-onset Alzheimer\u2019s disease (LOAD) genome-wide association studies (GWAS) Neurobiol Aging. Neurobiol. Aging. 33(8), 1849-e5 (2012).","journal-title":"Neurobiol. Aging."},{"key":"12054_CR58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41531-017-0015-3","volume":"3","author":"C Klemann","year":"2017","unstructured":"Klemann, C. et al. Integrated molecular landscape of Parkinson\u2019s disease. NPJ Parkinsons Dis. 3, 14 (2017).","journal-title":"NPJ Parkinsons Dis."},{"key":"12054_CR59","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ng.3955","volume":"49","author":"D Chang","year":"2017","unstructured":"Chang, D. et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci. Nat. Genet. 49, 1511\u20131516 (2017).","journal-title":"Nat. Genet."},{"key":"12054_CR60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang, Q., Liu, Y. & Zhou, J. Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl. Neurodegener. 4, 19 (2015).","journal-title":"Transl. Neurodegener."},{"key":"12054_CR61","doi-asserted-by":"publisher","first-page":"31664","DOI":"10.1074\/jbc.M504894200","volume":"280","author":"S Kubo","year":"2005","unstructured":"Kubo, S. et al. A combinatorial code for the interaction of alpha-synuclein with membranes. J. Biol. Chem. 280, 31664\u201331672 (2005).","journal-title":"J. Biol. Chem."},{"key":"12054_CR62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.expneurol.2017.12.002","volume":"301","author":"K Coulombe","year":"2018","unstructured":"Coulombe, K. et al. Impact of DHA intake in a mouse model of synucleinopathy. Exp. Neurol. 301, 39\u201349 (2018).","journal-title":"Exp. Neurol."},{"key":"12054_CR63","doi-asserted-by":"crossref","unstructured":"Stoessel D, Schulte C, Teixeira Dos Santos MC, Scheller D, Rebollo-Mesa I, Deuschle C, Walther D, Schauer N, Berg D, Nogueira da Costa A, Maetzler W. Promising metabolite profiles in the plasma and CSF of early clinical Parkinson\u2019s disease. Front. Aging Neurosci. 2018; 10: 51.","DOI":"10.3389\/fnagi.2018.00051"},{"issue":"12","key":"12054_CR64","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/metabo11120860","volume":"11","author":"M Pathan","year":"2021","unstructured":"Pathan, M., Wu, J., Lakso, H. \u00c5., Forsgren, L. & \u00d6hman, A. Plasma metabolite markers of Parkinson\u2019s disease and atypical Parkinsonism. Metabolites 11(12), 860 (2021).","journal-title":"Metabolites"},{"key":"12054_CR65","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.12659\/MSM.904399","volume":"23","author":"J Zhang","year":"2017","unstructured":"Zhang, J., Zhang, X., Wang, L. & Yang, C. High performance liquid chromatography-mass spectrometry (LC-MS) based quantitative lipidomics study of ganglioside-NANA-3 plasma to establish its association with Parkinson\u2019s disease patients. Med Sci Monit. 23, 5345\u20135353 (2017).","journal-title":"Med Sci Monit."},{"issue":"3","key":"12054_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191815","volume":"13","author":"PL Wood","year":"2018","unstructured":"Wood, P. L., Tippireddy, S., Feriante, J. & Woltjer, R. L. Augmented frontal cortex diacylglycerol levels in Parkinson\u2019s disease and Lewy body disease. PLoS ONE 13(3), e0191815 (2018).","journal-title":"PLoS ONE"},{"key":"12054_CR67","doi-asserted-by":"publisher","first-page":"175909141878188","DOI":"10.1177\/1759091418781889","volume":"10","author":"TN Seyfried","year":"2018","unstructured":"Seyfried, T. N. et al. Sex-related abnormalities in substantia Nigra lipids in Parkinson\u2019s disease. ASN Neuro 10, 1759091418781889 (2018).","journal-title":"ASN Neuro"},{"key":"12054_CR68","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.micres.2018.03.001","volume":"210","author":"O Akhberdi","year":"2018","unstructured":"Akhberdi, O. et al. Roles of phospholipid methyltransferases in pycnidia development, stress tolerance and secondary metabolism in the taxol-producing fungus Pestalotiopsis microspore. Microbiol. Res. 210, 33\u201342 (2018).","journal-title":"Microbiol. Res."},{"issue":"4","key":"12054_CR69","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3233\/JAD-150290","volume":"46","author":"RJ Wurtman","year":"2015","unstructured":"Wurtman, R. J. How anticholinergic drugs might promote Alzheimer\u2019s disease: More amyloid-\u03b2 and less phosphatidylcholine. J. Alzheimers Dis. 46(4), 983\u2013987 (2015).","journal-title":"J. Alzheimers Dis."},{"issue":"9\u201310","key":"12054_CR70","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","volume":"17","author":"N Fabelo","year":"2011","unstructured":"Fabelo, N. et al. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson\u2019s disease and incidental Parkinson\u2019s disease. Mol. Med. 17(9\u201310), 1107\u20131118 (2011).","journal-title":"Mol. Med."},{"issue":"2","key":"12054_CR71","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1021\/acschemneuro.3c00671","volume":"15","author":"K Zhaliazka","year":"2024","unstructured":"Zhaliazka, K., Ali, A. & Kurouski, D. Phospholipids and cholesterol determine molecular mechanisms of cytotoxicity of \u03b1-synuclein oligomers and fibrils. ACS Chem. Neurosci. 15(2), 371\u2013381 (2024).","journal-title":"ACS Chem. Neurosci."},{"issue":"Pt 1","key":"12054_CR72","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1042\/BJ20051277","volume":"393","author":"A Trostchansky","year":"2006","unstructured":"Trostchansky, A. et al. Interaction with phospholipids modulates alpha-synuclein nitration and lipid-protein adduct formation. Biochem. J. 393(Pt 1), 343\u2013349 (2006).","journal-title":"Biochem. J."},{"issue":"16","key":"12054_CR73","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1021\/acschemneuro.2c00355","volume":"13","author":"T Dou","year":"2022","unstructured":"Dou, T. & Kurouski, D. Phosphatidylcholine and phosphatidylserine uniquely modify the secondary structure of \u03b1-synuclein oligomers formed in their presence at the early stages of protein aggregation. ACS Chem. Neurosci. 13(16), 2380\u20132385 (2022).","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"12054_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2020.183536","volume":"1863","author":"G Musteikyt\u0117","year":"2021","unstructured":"Musteikyt\u0117, G. et al. Interactions of \u03b1-synuclein oligomers with lipid membranes. Biochim. Biophys. Acta Biomembr. 1863(4), 183536 (2021).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"3","key":"12054_CR75","doi-asserted-by":"publisher","first-page":"109189","DOI":"10.1016\/j.isci.2024.109189","volume":"27","author":"H Shiino","year":"2024","unstructured":"Shiino, H. et al. Chemical inhibition of phosphatidylcholine biogenesis reveals its role in mitochondrial division. iScience. 27(3), 109189 (2024).","journal-title":"iScience."},{"issue":"1","key":"12054_CR76","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tcb.2009.09.008","volume":"20","author":"F Sesti","year":"2010","unstructured":"Sesti, F., Liu, S. & Cai, S. Q. Oxidation of potassium channels by ROS: a general mechanism of aging and neurodegeneration?. Trends Cell Biol. 20(1), 45\u201351 (2010).","journal-title":"Trends Cell Biol."},{"issue":"7","key":"12054_CR77","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/nu14071414","volume":"14","author":"CJ Andersen","year":"2022","unstructured":"Andersen, C. J. Lipid metabolism in inflammation and immune function. Nutrients 14(7), 1414 (2022).","journal-title":"Nutrients"},{"issue":"1\u20132","key":"12054_CR78","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11010-006-9280-x","volume":"295","author":"N Aiyar","year":"2007","unstructured":"Aiyar, N. et al. Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells. Mol. Cell Biochem. 295(1\u20132), 113\u2013120 (2007).","journal-title":"Mol. Cell Biochem."},{"issue":"15","key":"12054_CR79","doi-asserted-by":"publisher","first-page":"8274","DOI":"10.3390\/ijms23158274","volume":"23","author":"J Ren","year":"2022","unstructured":"Ren, J., Lin, J., Yu, L. & Yan, M. Lysophosphatidylcholine: potential target for the treatment of chronic pain. Int. J. Mol. Sci. 23(15), 8274 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"12054_CR80","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12974-022-02557-0","volume":"19","author":"Y Xie","year":"2022","unstructured":"Xie, Y. et al. Transforming growth factor-\u03b21 protects against LPC-induced cognitive deficit by attenuating pyroptosis of microglia via NF-\u03baB\/ERK1\/2 pathways. J Neuroinflammation. 19(1), 194 (2022).","journal-title":"J Neuroinflammation."},{"issue":"108","key":"12054_CR81","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2022.12.001","volume":"1","author":"HK Hughes","year":"2023","unstructured":"Hughes, H. K., Moreno, R. J. & Ashwood, P. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD). Brain, Behav. Immun. 1(108), 245\u201354 (2023).","journal-title":"Brain, Behav. Immun."},{"issue":"4","key":"12054_CR82","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41435-020-0104-x","volume":"21","author":"EA Caseley","year":"2020","unstructured":"Caseley, E. A., Poulter, J. A. & Rodrigues, F. Immunome project consortium for autoinflammatory disorders (ImmunAID) Caseley Emily A. 1 Poulter James A. 1, McDermott MF. Inflammasome inhibition under physiological and pharmacological conditions. Genes Immun. 21(4), 211\u201323 (2020).","journal-title":"Genes Immun."},{"issue":"11","key":"12054_CR83","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","volume":"15","author":"X Han","year":"2019","unstructured":"Han, X. et al. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: Implications for Parkinson disease. Autophagy 15(11), 1860\u20131881 (2019).","journal-title":"Autophagy"},{"key":"12054_CR84","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbi.2020.09.017","volume":"91","author":"S Ahmed","year":"2021","unstructured":"Ahmed, S., Kwatra, M., Ranjan Panda, S., Murty, U. S. N. & Naidu, V. G. M. Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease. Brain Behav Immun. 91, 142\u2013158 (2021).","journal-title":"Brain Behav Immun."},{"issue":"12","key":"12054_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.626842","volume":"15","author":"M Di Gioia","year":"2021","unstructured":"Di Gioia, M. & Zanoni, I. Dooming phagocyte responses: Inflammatory effects of endogenous oxidized phospholipids. Front Endocrinol. 15(12), 626842 (2021).","journal-title":"Front Endocrinol."},{"issue":"5","key":"12054_CR86","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/jnr.21206","volume":"85","author":"J Qin","year":"2007","unstructured":"Qin, J., Goswami, R., Balabanov, R. & Dawson, G. Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain. J. Neurosci. Res. 85(5), 977\u2013984 (2007).","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"12054_CR87","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1189\/jlb.3VMA1215-579RR","volume":"101","author":"SH Yeon","year":"2017","unstructured":"Yeon, S. H., Yang, G., Lee, H. E. & Lee, J. Y. Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages. J. Leukoc. Biol. 101(1), 205\u2013215 (2017).","journal-title":"J. Leukoc. Biol."},{"issue":"13","key":"12054_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.829425","volume":"8","author":"Q Zhu","year":"2022","unstructured":"Zhu, Q. et al. Comprehensive metabolic profiling of inflammation indicated key roles of glycerophospholipid and arginine metabolism in coronary artery disease. Front. Immunol. 8(13), 829425 (2022).","journal-title":"Front. Immunol."},{"issue":"3","key":"12054_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100056","volume":"11","author":"A Mendes-Frias","year":"2020","unstructured":"Mendes-Frias, A. et al. Dysregulation of glycerophospholipid metabolism during Beh\u00e7et\u2019s disease contributes to a pro-inflammatory phenotype of circulating monocytes. J. Transl. Autoimmun. 11(3), 100056 (2020).","journal-title":"J. Transl. Autoimmun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12054-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12054-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12054-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:00:34Z","timestamp":1757329234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12054-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12054"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12054-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study only involves publicly available GWAS statistical abstracts and does not capture individual-level data, therefore is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28093"}}